Biosensors Market Size By Type, By Technology, By Medical Application, By End-use, Regional Outlook, Industry Analysis Report, Growth Potential, Competitive Market Share & Forecast, 2023

Description

List of Tables

Biosensors Market is expected to grow considerably through 2032, owing to the rising demand for home-based point-of-care devices and portable biosensors, particularly across the APAC economies. In addition, the availability of a wide range of commercially available products related to point-of-care diagnosis for parasitic, viral, and bacterial infections will positively impact the overall industry growth.

Although, the market growth is expected to be hampered due to strict regulations set by various governments for safer and more effective employment of biosensors in medical devices. Nevertheless, the ongoing tech innovations, collaborations, and partnerships undertaken by leading behemoths will stimulate the industry growth. Furthermore, the rising adoption of innovative bio-sensing technologies will also boost the market dynamics during 2023-2032.

Overall, the biosensors market is segmented in terms of type, technology, medical application, end-use, and region.

Considering the type, the wearable biosensors segment held over USD 17 billion revenue share in 2022. The ability of wearable biosensors to continuously monitor vital signs, provide feedback to the user, and provide prompt illness prevention, diagnosis, and treatment will increase their penetration over the due course of time.

Based on technology, the electrochemical segment is projected to record significant returns throughout 2023-2032, owing to the ongoing technological achievements in the industry. Technological innovations have led to highly sensitive electrochemical analysis that enhances ECG, heart rate, and EEG measurement. Ongoing R&D projects regarding electrochemical biosensors is likely to impact the market growth. Recently, a study was carried out around a wearable electrochemical biosensor for monitoring metabolites in sweat post vigorous exercises.

By medical application, the blood glucose testing segment accounted for over 71.5% market share in 2022 and is estimated to register significant growth through 2032. The growth can be attributed to the increasing research and advancements in biosensor design for monitoring glucose in bodily fluids other than blood.

Considering the end-user, the point-of-care testing biosensor segment is anticipated to demonstrate robust growth through 2032, owing to its features such as remote health monitoring and real-time diagnostic analysis. Besides, the ongoing research on introducing effective POC testing kits to manage the burden of point-of-care testing facilities will be a positive factor driving the segmental demand in the future.

Regionally, the North America biosensors market would witness prolific gains over 2023-2032 owing to the rising prevalence of infectious diseases and mounting adoption of POC-based diagnostic devices for safe and early disease detection. In addition, the availability of highly advanced medical framework and sophisticated co-payment and insurance systems will further enhance the overall regional market growth in the future.

Product Code: 747

Chapter 1 Methodology & Scope

1.1 Methodology
1.2 Base estimates and calculations
- 1.2.1 North America
- 1.2.2 Europe
- 1.2.3 Asia Pacific
- 1.2.4 Latin America
- 1.2.5 MEA
1.3 Forecast calculations
1.4 Data validation
1.5 Data sources
- 1.5.1 Secondary
  - 1.5.1.1 Paid sources
  - 1.5.1.2 Unpaid sources
- 1.5.2 Primary

Chapter 2 Executive Summary

2.1 Biosensors market industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Device trends
- 2.1.3 Application trends
- 2.1.4 End-use trends
- 2.1.5 Regional trends

Chapter 3 Biosensors Industry Insights

3.1 Industry segmentation
3.2 Industry ecosystem analysis
- 3.2.1 Vendor Matrix
- 3.2.2 Distribution channel analysis
- 3.2.3 Profit margin trends
3.3 Raw material analysis
- 3.3.1 Nanomaterials
- 3.3.2 Polymers
- 3.3.3 Semiconductors
- 3.3.4 Others
3.3 Pricing analysis 2018 - 2032
- 3.3.1 Pricing analysis, by region
  - 3.3.1.1 North America
  - 3.3.1.2 Europe
  - 3.3.1.3 Asia Pacific
  - 3.3.1.4 Latin America
  - 3.3.1.5 Middle East & Africa
3.4 Cost structure analysis
- 3.4.1 Component/material costs
- 3.4.2 Manufacturing & labour costs
- 3.4.3 Utilities
- 3.4.4 Maintenance cost
- 3.4.5 Finance cost
- 3.4.6 Administration cost
- 3.4.7 Others
3.5 Industry impact forces
- 3.5.1 Growth drivers
  - 3.5.1.1 Growing application of biosensors in medical field
  - 3.5.1.2 Rising prevalence of diabetes globally
  - 3.5.1.3 High demand for portable biosensors in Asia Pacific and Europe
  - 3.5.1.4 Technological advancements
- 3.5.2 Industry pitfalls & challenges
  - 3.5.2.1 Stringent regulatory scenario
  - 3.5.2.2 High cost of product development
3.6 Growth potential analysis
- 3.6.1 By type
- 3.6.2 By technology
- 3.6.3 By medical application
- 3.6.4 By end-use
3.7 COVID- 19 impact analysis
3.8 Regulatory landscape
- 3.8.1 U.S.
- 3.8.2 Europe
3.9 Technology landscape
3.10 Industry eco-system
- 3.10.1 Current trends in the industry
- 3.10.2 Start-up scenario
3.11 Porter's analysis
- 3.11.1 Bargaining power of suppliers
- 3.11.2 Bargaining power of buyers
- 3.11.3 Threat of new entrants
- 3.11.4 Threat of substitutes
- 3.11.5 Industry rivalry
3.12 PESTEL analysis
- 3.12.1 Political
- 3.12.2 Economical
- 3.12.3 Social
- 3.12.4 Technological
- 3.12.5 Environmental
- 3.12.6 Legal

Chapter 4 Competitive landscape

4.1 Introduction
4.2 Company market share, 2021
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic outlook matrix

Chapter 5 Biosensors Market, By Type

5.1 Key type trends
5.2 Wearable biosensors
5.3 Non-wearable biosensors

Chapter 6 Biosensors Market, By Technology

6.1 Key technology trends
6.2 Electrochemical
6.3 Optical
6.4 Thermal
6.5 Piezoelectric
6.6 Others

Chapter 7 Biosensors Market, By Medical Application

7.1 Key medical application trends
7.2 Blood glucose testing
7.3 Cholesterol testing
7.4 Blood gas analysis
7.5 Pregnancy testing
7.6 Drug discovery
7.7 Infectious disease testing
7.8 Others

Chapter 8 Biosensors Market, By End-use

8.1 Key end-use trends
8.2 Point of care testing
8.3 Home healthcare diagnostics
8.4 Research laboratories
8.5 Others

Chapter 9 Biosensors Market, By Region

9.1 Key regional trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Russia
- 9.3.7 Switzerland
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
9.6 Middle East & Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia

Chapter 10 Company Profiles

10.1 F. Hoffmann-La Roche Ltd
10.2 Abbott Laboratories
10.3 Thermo Fisher Scientific Inc.
10.4 Danaher Corporation
10.5 Siemens Healthineers AG
10.6 Ascensia Diabetes Care Holdings AG
10.7 Bio-Rad Laboratories, Inc
10.8 Biosensors International Group, Ltd
10.9 Dexcom, Inc.
10.10 LifeScan Inc.
10.11 Masimo
10.12 Nova Biomedical
10.13 Pinnacle Technology
10.14 QTL Biosystems
10.15 TE Connectivity Corporation